Radiolabeling Diaminosarcophagine with Cyclotron-Produced Cobalt-55 and [<sup>55</sup>Co]Co-NT-Sarcage as a Proof of Concept in a Murine Xenograft Model-Reference-Cited by-同舟云学术

Radiolabeling Diaminosarcophagine with Cyclotron-Produced Cobalt-55 and [⁵⁵Co]Co-NT-Sarcage as a Proof of Concept in a Murine Xenograft Model

Published:2024-02-27 Issue:3 Volume:35 Page:412-418
ISSN:1043-1802
Container-title:Bioconjugate Chemistry
language:en
Short-container-title:Bioconjugate Chem.

Author:

Lin Wilson¹^ORCID,Fonseca Cabrera German Oscar²,Aluicio-Sarduy Eduardo¹,Barnhart Todd E.¹,Mixdorf Jason C.¹,Li Zibo²^ORCID,Wu Zhanhong²,Engle Jonathan W.¹³^ORCID

Affiliation:

1. Department of Medical Physics, University of Wisconsin, 1111 Highland Avenue, Madison, Wisconsin 53705, United States

2. Department of Radiology and Biomedical Research Imaging Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States

3. Department of Radiology, University of Wisconsin, 600 Highland Avenue, Madison, Wisconsin 53792, United States

Funder

Clinical Center

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.bioconjchem.4c00043

Reference38 articles.

1. PET imaging of tumours with a64Cu labeled macrobicyclic cage amine ligand tethered to Tyr3-octreotate

2. Peptide Receptor Radionuclide Therapy with 67Cu-CuSarTATE Is Highly Efficacious Against a Somatostatin-Positive Neuroendocrine Tumor Model

3. The role of coordination chemistry in the development of copper and rhenium radiopharmaceuticals

4. Preclinical Evaluation of a High-Affinity Sarcophagine-Containing PSMA Ligand for 64Cu/67Cu-Based Theranostics in Prostate Cancer

5. Copper-67-Labeled Bombesin Peptide for Targeted Radionuclide Therapy of Prostate Cancer

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Scalability study on [133La]LaCl3 production with a focus on potential clinical applications;EJNMMI Radiopharmacy and Chemistry;2024-08-15

2. Synthesis of⁶⁴Cu-,⁵⁵Co-, and⁶⁸Ga-Labeled Radiopharmaceuticals Targeting Neurotensin Receptor-1 for Theranostics: Adjusting In Vivo Distribution Using Multiamine Macrocycles;Journal of Nuclear Medicine;2024-06-13